和邦生物 (603077.SH)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务分析(报告期)(和邦生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
主要指标:
 营业收入(元) 6,434,462,278.944,090,613,303.822,394,468,174.8413,038,947,986.8010,493,324,771.697,479,029,894.833,086,136,455.48
 营业利润(元) 1,210,602,688.47729,549,281.19477,206,214.044,481,157,181.564,041,494,818.243,106,064,980.991,230,073,011.36
 利润总额(元) 1,209,838,849.38728,835,852.35476,583,819.354,478,562,143.584,039,014,941.653,103,610,527.521,227,629,210.97
 净利润(元) 1,014,075,433.12603,141,895.11381,460,623.903,810,238,934.753,434,367,991.422,640,754,408.311,045,126,299.13
 归属于母公司股东的净利润(元) 1,019,044,364.44616,531,723.76396,561,190.753,806,808,869.243,427,501,728.442,634,634,940.011,042,725,403.09
盈利能力:
 销售毛利率(%) 24.0623.6126.1042.8545.6848.3647.61
 销售净利率(%) 15.7614.7415.9329.2232.7335.3133.87
 净资产收益率(%) 5.313.332.23----
 总资产报酬率ROA(%) 5.033.152.20----
 投入资本回报率ROIC(%) 4.722.931.8720.7919.1215.166.33
营运能力:
 存货周转率(次) 1.851.370.98----
 应收账款周转率(次) 5.744.042.55----
 总资产周转率(次) 0.270.180.11----
偿债能力:
 资产负债率(%) 17.8515.5316.0918.0016.8218.3016.42
 股东权益比率(%) 79.5681.7881.3079.3280.9179.4081.33
 已获利息倍数(倍) -169.50-179.9498.48186.63156.34186.60157.94
 流动比率 2.903.002.772.602.492.242.29
 速动比率 1.691.842.021.992.031.861.74
发展能力:
 营业收入增长率(%) -38.68-45.31-22.4130.5547.2389.3685.43
 营业利润增长率(%) -70.05-76.51-61.2124.7969.15188.51326.65
 税后利润增长率(%) -70.27-76.60-61.9726.1270.69188.80323.44
 净资产增长率(%) 6.279.7821.7534.2140.6845.6442.98
 总资产增长率(%) 8.086.5921.7934.4837.6442.7934.71

前瞻产业研究院